Prescription Drug Matzim LA Extended-Release Tablets Recalled for Failed Dissolution
Teva Pharmaceuticals is recalling Matzim LA (Diltiazem Hydrochloride) 180 mg tablets because they failed to meet dissolution specifications. The recall affects approximately 8,022 bottles distributed nationwide in the United States and Puerto Rico.
- Product
- MATZIM LA — MATZIM LA (DILTIAZEM HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide